<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>4(11 Pt 1)</volume><submitter>Ozaki S</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Introduced in 2007, the Ozaki procedure-templated cusp replacement with autologous pericardium-is a new option for treating aortic valve disease. Mid-term outcomes and valve performance have not yet been reported.&lt;h4>Objectives&lt;/h4>This study assesses longitudinal hemodynamics, left ventricular reverse remodeling, reoperation, and survival in the original Ozaki cohort.&lt;h4>Methods&lt;/h4>1,196 patients underwent Ozaki procedures (60% male, age 11-90 years) at Toho University Ohashi Medical Center from April 2007 to May 2021: 2.4% had infective endocarditis, 27% had bicuspid valves, 54% had aortic stenosis, 24% had aortic regurgitation, 7.3% had mixed lesions, and 46% underwent concomitant procedures. Clinical outcomes, echocardiograms, and follow-up data (50% followed >3.2 y</pubmed_abstract><journal>JACC. Advances</journal><pagination>102156</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12589979</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Mid-Term Experience With 1,196 Ozaki Procedures.</pubmed_title><pmcid>PMC12589979</pmcid><pubmed_authors>Takatoo M</pubmed_authors><pubmed_authors>Shimura S</pubmed_authors><pubmed_authors>Goda M</pubmed_authors><pubmed_authors>Ozaki S</pubmed_authors><pubmed_authors>Hoshino Y</pubmed_authors><pubmed_authors>Hayama H</pubmed_authors><pubmed_authors>Rajeswaran J</pubmed_authors><pubmed_authors>Svensson LG</pubmed_authors><pubmed_authors>Kiyohara N</pubmed_authors><pubmed_authors>Unai S</pubmed_authors><pubmed_authors>Pettersson GB</pubmed_authors><pubmed_authors>Frankel WC</pubmed_authors><pubmed_authors>Harb SC</pubmed_authors><pubmed_authors>Blackstone EH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Mid-Term Experience With 1,196 Ozaki Procedures.</name><description>&lt;h4>Background&lt;/h4>Introduced in 2007, the Ozaki procedure-templated cusp replacement with autologous pericardium-is a new option for treating aortic valve disease. Mid-term outcomes and valve performance have not yet been reported.&lt;h4>Objectives&lt;/h4>This study assesses longitudinal hemodynamics, left ventricular reverse remodeling, reoperation, and survival in the original Ozaki cohort.&lt;h4>Methods&lt;/h4>1,196 patients underwent Ozaki procedures (60% male, age 11-90 years) at Toho University Ohashi Medical Center from April 2007 to May 2021: 2.4% had infective endocarditis, 27% had bicuspid valves, 54% had aortic stenosis, 24% had aortic regurgitation, 7.3% had mixed lesions, and 46% underwent concomitant procedures. Clinical outcomes, echocardiograms, and follow-up data (50% followed >3.2 y</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Nov</publication><modification>2026-07-15T11:16:14.913Z</modification><creation>2026-07-04T03:11:48.365Z</creation></dates><accession>S-EPMC12589979</accession><cross_references><pubmed>41124984</pubmed><doi>10.1016/j.jacadv.2025.102156</doi></cross_references></HashMap>